OptimizeRx (OPRX) Notes Payables (2010 - 2020)
OptimizeRx (OPRX) posted Notes Payables of $285795.0 for Q4 2020, down 50.73% sequentially from $580014.0 in Q4 2019, and down 50.73% YoY from $580014.0 in Q1 2020.
OptimizeRx (OPRX) Notes Payables (2010 - 2020) Analysis & Trends
OptimizeRx has reported Notes Payables for 6 years, with the latest figure at $285795.0 in Q4 2020.
- Quarterly Notes Payables fell 50.73% year-over-year to $285795.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $285795.0 (down 50.73% YoY) and the FY2020 annual result came in at $285795.0, down 50.73% from the prior year.
- Notes Payables fell to $285795.0 in Q4 2020 per OPRX's latest filing, from $580014.0 in the prior quarter.
- Over five years, Notes Payables peaked at $580014.0 in Q4 2019 and troughed at $285795.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn |
| 10 | OptimizeRx | 164.25 Mn | 140.15 Mn | 15.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 285,795.00 |
| Dec 31, 2019 | 580,014.00 |
| Dec 31, 2015 | 570,000.00 |
| Sep 30, 2015 | 570,000.00 |
| Jun 30, 2015 | 570,000.00 |
| Mar 31, 2015 | 570,000.00 |
| Dec 31, 2014 | 570,000.00 |
| Sep 30, 2014 | 570,000.00 |
| Dec 31, 2013 | 570,000.00 |
| Dec 31, 2010 | 570,000.00 |